Topics and Expertise: nanobodies

Nanobody-based antiviral developed at UCSF effectively blocks SARS-CoV-2 in the lab

Wed Aug 12, 2020
Aerosol spray
Noah Berger

The antiviral invented by Aashish Manglik, PhD, and colleagues is effective at blocking SARS-CoV-2 infection even as an aerosolized spray, according to laboratory testing.

School scientists developed an antiviral that fights SARS-CoV-2 that can be given as a nasal spray.